More on MDCX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/20/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Medicus Pharma (NQ:MDCX)
Delayed: 0.46 +0.11 (31.43%)
Prev. Close $0.35  
Open$0.36 
52 Wk High$ 
52 Wk Low$ 
Day High$0.48 
Day Low$0.36 
P/E N/A  
EPS$ 
Volume12,185,101 

Friends, Peers and Foes (?): MDPLF, DVLT, VTIX, YYGH, RDZN (more...)

Jun 20, 2026 01:30 PM New to The Street broadcasts show #758 TODAY AT 6:30 PM ET on BLOOMBERG TELEVISION ACROSS THE UNITED STATES, LATIN AMERICA, AND MENA
Jun 15, 2026 07:30 AM Medicus Pharma submits rare pediatric disease designation request for SkinJect
Jun 15, 2026 07:30 AM Medicus Pharma Announces U.S. Food and Drug Administration (FDA) Submission of Rare Pediatric Disease Designation Request for SkinJect® in Gorlin Syndrome
Jun 12, 2026 02:45 PM New to The Street Broadcasting Saturday June 13th 630pm est ACROSS BLOOMBERG TELEVISION IN THE U.S., LATIN AMERICA, AND MENA
Jun 11, 2026 07:30 AM Medicus Pharma starts genomic endometriosis trial in UAE
Jun 11, 2026 07:30 AM Medicus Pharma Initiates Groundbreaking PRECISION-E2 Phase 2a Study of Teverelix® in Endometriosis utilizing the Emirati Genome Program
Jun 8, 2026 07:32 AM Medicus Pharma submits European filing for Teverelix prostate cancer study
Jun 8, 2026 07:30 AM Medicus Pharma Advances Teverelix® Program Towards Registrational Development Targeting High Cardiovascular-Risk Prostate Cancer Patients with Key European Submission
Jun 6, 2026 11:20 AM New to The Street Broadcasts Tonight on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM ET
Jun 4, 2026 05:04 PM Form 424B3 Medicus Pharma Ltd.
View All Articles

Entities mentioned with MDCX

View All Entities